Juergen Froehlich
Chief Tech/Sci/R&D Officer bei ARCTURUS THERAPEUTICS HOLDINGS INC.
Vermögen: - $ am 31.03.2024
Aktive Positionen von Juergen Froehlich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| APPILI THERAPEUTICS INC. | Director/Board Member | 27.01.2020 | - |
| Independent Dir/Board Member | 27.01.2020 | - | |
| SPEXIS AG | Chief Tech/Sci/R&D Officer | 30.12.2021 | - |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Chief Tech/Sci/R&D Officer | - | - |
| Sales & Marketing | 01.03.2023 | - |
Karriereverlauf von Juergen Froehlich
Ehemalige bekannte Positionen von Juergen Froehlich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Sales & Marketing | 01.01.2022 | 01.04.2023 |
| ARADIGM CORPORATION | Chief Tech/Sci/R&D Officer | 31.05.2018 | 14.02.2019 |
| ARADIGM CORPORATION | Chief Tech/Sci/R&D Officer | 01.11.2013 | 11.02.2018 |
| General Counsel | 01.11.2013 | 11.02.2018 | |
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 01.10.2011 | 01.09.2013 |
Ausbildung von Juergen Froehlich
| State University of New York at Albany | Masters Business Admin |
| Graduate School of Business Administration Zürich | Masters Business Admin |
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Schweiz | 3 |
| Deutschland | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| General Counsel | 2 |
| Masters Business Admin | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| SPEXIS AG | Health Technology |
| APPILI THERAPEUTICS INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
- Börse
- Insiders
- Juergen Froehlich
- Erfahrung
